Evidence map›Paper›PMID 24847335›Full record

ReviewCardiorenal medicine2014

Arterial Stiffness: A Nexus between Cardiac and Renal Disease.

Guanghong Jia, Annayya R Aroor, James R Sowers

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiorenal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Association of central arterial stiffness with atrial myopathy: the Atherosclerosis Risk in Communities (ARIC) study.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Role of adropin in arterial stiffening associated with obesity and type 2 diabetes.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Elevated pulse amplification in hypertensive patients with advanced kidney disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Guanghong JiaDivision of Endocrinology, Diabetes, and Metabolism, Mo., USA ; Diabetes Cardiovascular Center, Mo., USA ; Harry S. Truman Memorial Veterans Hospital, Columbia, Mo., USA.
Annayya R AroorDivision of Endocrinology, Diabetes, and Metabolism, Mo., USA ; Diabetes Cardiovascular Center, Mo., USA ; Harry S. Truman Memorial Veterans Hospital, Columbia, Mo., USA.
James R SowersDivision of Endocrinology, Diabetes, and Metabolism, Mo., USA ; Diabetes Cardiovascular Center, Mo., USA ; Department of Medical Pharmacology and Physiology, Mo., USA ; Harry S. Truman Memorial Veterans Hospital, Columbia, Mo., USA.
Harry S. Truman Memorial Veterans' Hospital · US

Funding

ANG II OPPOSES INS MEDIATED VASORELAXATION &GLU UTILZAR01HL073101 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SOWERS, JAMES RUSSELL · 2004 to 2013
$2.7M
Ang II and Overnutrition and Insulin resistance in Cardiovascular TissueR01HL107910 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SOWERS, JAMES RUSSELL · 2011 to 2015
$1.8M
Interactions of the RAAS and a Western Diet on Insulin Metabolic ActionsI01BX001981 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI LASTRA, GUIDO · 2013 to 2022
–
NHLBI NIH HHS R01 HL073101NHLBI NIH HHS R01 HL107910
6 · The paper itself

Abstract

Vascular disease is the leading cause of morbidity and mortality in the Western world, and vascular function is determined by structural and functional properties of the arterial vascular wall. Cardiorenal metabolic syndrome such as obesity, diabetes, hypertension, kidney disease, and aging are conditions that predispose to arterial stiffening, which is a pathological alteration of the vascular wall and ultimately results in target organ damage in heart and kidney. In this review, we provide new insights on the interactions between arterial stiffness, vascular resistance and pulse wave velocity as well as final end-organ damage in heart and kidney. Better understanding of the mechanisms of arterial functional and hemodynamic alteration may help in developing more refined therapeutic strategies aimed to reduce cardiovascular and chronic kidney diseases.

Indexed as

Arterial stiffnessCardiorenal metabolic syndromeEndothelial cellsEstrogenVascular smooth muscle cells

Identifiers

PMID24847335
PMCPMC4024508
OpenAlexW2097424111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.